Prof. Lucia Gemma Delogu is a pioneering researcher at the forefront of nanotechnology applications in medicine. She leads the ImmuneNano Lab at UNIPD, which specializes in the implementation of carbon-based nanomaterials (CBMs) such as graphene, aminated graphene, graphene oxide, graphene nanoribbons, and carbon nanotube fibers. Prof. Delogu's work is recognized internationally, collaborating with leaders in nanomaterial synthesis and characterization.

Her significant contributions include spearheading two major European projects: G-IMMUNOMICS, under the European Graphene Flagship, and Carbo-IMMAP, funded by HORIZON 2020. Prof. Delogu introduced the innovative "NanoImmunity-by-design" concept, emphasizing the immune properties of nanomaterials alongside their physicochemical attributes. Her research has set new standards in theranostics, particularly through her seminal work on the echogenic properties of functionalized carbon nanotubes, which has greatly advanced ultrasonography-based applications.

Additionally, Prof. Delogu was the first to explore amino-functionalized carbon materials as immunomodulatory systems, a breakthrough in the field of immunotherapy and space biology. Her recent work includes groundbreaking studies on graphene's role in inducing T helper 1 immune responses, crucial for immune-mediated tumor regression, marking significant progress in nano-based cancer treatments. These contributions not only continue to push the boundaries of nanotechnology and medicine but also influence related fields like space biology within the graphene scientific community.